Hormone pretreatment study for women with adenomyosis
Part of Women’s health & pregnancy clinical trials.
This trial studies whether adjusting the length of pre-treatment with a hormone blocker (GnRH agonist) and adding letrozole before a frozen embryo transfer can improve pregnancy outcomes for people with adenomyosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with adenomyosis (uterine lining grows into muscle) via ultrasound.
- You are planning to transfer a single frozen embryo (blastocyst stage).
- You are between 20 and 38 years old.
- You have had 2 or fewer previous embryo transfers.
- You do not have conditions like recurrent pregnancy loss, autoimmune disorders, large fibroids, or cervical weakness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding letrozole (a medication that lowers estrogen) to standard hormone therapy helps women with adenomyosis have a better chance of pregnancy during in vitro fertilization (IVF). If you have adenomyosis and are planning an IVF cycle with one embryo transfer, this study may be a good fit.
This trial tests if the drug nintedanib can improve pregnancy rates in women with adenomyosis who are undergoing IVF. It is for women who have at least one high-quality frozen embryo and want to see if this medication helps the embryo implant successfully.
This trial explores how natural uterine contractions affect pregnancy success in women using hormone therapy for frozen embryo transfer. It may help doctors understand if uterine activity influences implantation.
This study tests whether using a hormone medication (GnRH agonist) before a frozen embryo transfer helps women with adenomyosis. If you have adenomyosis and are planning a frozen embryo transfer, this trial will help compare results with or without the pre-treatment.
This trial looks at whether frozen embryo transfer can help women with adenomyosis (a condition where the inner lining of the uterus grows into its muscle wall) who have trouble getting pregnant. It aims to understand if this method improves pregnancy chances.
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
Hear when a new Adenomyosis of Uterus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.